Immune cell therapy for glioblastoma
Part of Cancer clinical trials.
This study is testing a new type of immune cell therapy (cytokine-induced killer cells) for people with glioblastoma, a type of brain cancer. The treatment may boost your immune system to fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with glioblastoma (a type of brain cancer)
- You are willing to give informed consent (agree to take part after understanding the study)
- You do not have an active infection, autoimmune disease, or immune deficiency
- You are not pregnant
- Your blood counts (white cells, red cells, platelets) are within normal limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment using your own immune cells, called cytokine-induced killer cells, to fight advanced brain cancer (glioblastoma). It may help people whose cancer has returned after standard chemotherapy.
This trial tests whether giving patients immune cells called cytokine-induced killer cells can help treat early-stage brain tumors (grade 1 or 2 gliomas). It may help keep the tumor from growing or coming back after standard treatments like radiation and chemotherapy.
This trial tests a vaccine made from your own immune cells to fight glioblastoma, a type of brain cancer. It may help your body attack the cancer more effectively after standard treatments.
This study is testing special immune cells (called CAR-T cells) in the laboratory to see if they can attack glioblastoma tumor cells. It's a research study that uses a blood sample to grow and test these cells, and it may help find new ways to treat this type of brain tumor.
This trial tests a personalized immune cell treatment for a glioblastoma brain tumor that has a specific marker called EGFRvIII. The cells are made in a lab and given by infusion, and the study aims to see if they can safely target and attack the tumor.
This trial tests an experimental 'vaccine' made from your own immune cells (dendritic cells). The vaccine is designed to train your immune system to attack the brain tumor. It is for people whose glioblastoma has returned or progressed after standard treatment.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.